1. Catalogs
  2. iCAD
  3. ProFound AI® Risk
video corpo

ProFound AI® Risk

ProFound AI® Risk

ProFound AI® Risk

Product catalog summary
Overview: ProFound AI® Risk is a clinical decision support tool designed for 2D and 3D mammography, providing personalized short-term breast cancer risk estimation. It is the first of its kind to offer such precision based solely on mammogram data.
Key Features:
  • Combines various risk factors for superior short-term risk assessment compared to traditional models.
  • Includes racial and ethnic considerations for equitable precision screening.
  • Aligns with global screening guidelines and country-specific incidence and mortality data.
Benefits:
  • Offers one, two, or three-year risk estimations.
  • Ethnically inclusive, providing an equitable screening solution.
  • Up to 2.4 times more accurate than traditional risk models.
  • Easy implementation using data from 2D or 3D mammograms.
  • Supports the Institute for Health Care Improvement’s Quadruple Aim.
Clinical Performance: ProFound AI Risk provides the highest Area Under the Curve (AUC) for one-year risk estimation, enhancing the ability to tailor breast screening regimens and potentially identify cancers earlier.
Comprehensive Solution: iCAD’s portfolio supports breast cancer detection, density measurement, personalized risk assessment, and targeted radiation therapy, aiming to optimize efficiency and improve patient outcomes.
Regulatory Status: ProFound AI Risk is CE Marked, Health Canada Licensed, and available for investigational use in the U.S.
See more

Catalog excerpts

ProFound AI® Risk-1

ProFound AI® Risk* Revolutionizing Personalized Screening Risk Assessment Reimagined Available for 2D and 3D mammography, ProFound AI® Risk is the world’s first clinical decision support tool that provides an accurate short-term, breast cancer risk estimation that is truly personalized for each woman, based only on a 2D or 3D mammogram.1,2 Offers flexibility to provide a one, two or three-year risk estimation The easy-to-implement solution provides superior insights1,2 that empower clinicians to tailor a woman’s breast screening regimen and potentially identify cancers earlier. ProFound AI Risk uniquely combines a range of risk factors, offering superior performance in assessing short-term risk compared to traditional breast cancer risk models.1,2 Superior Accuracy Up to 2.4 times more accurate than traditional risk models.1, 2 Simplified Workflow Efficient and easy to implement solution provides a rapid short-term risk estimate. Personalized Care Latest version offers enhanced features to further individualize patient care. Personalized Screening Made Easy Ethnically inclusive precision screening offers equitable, firstin-kind solution Greater accuracy compared to previous versions and traditionally used risk models1,2 Easy-to-implement, using only information readily available in a 2D or 3D mammogram Aligns with the Institute for Health Care Improvement’s Quadruple Aim optimization of health system performance Visit icadmed.com to request a demo Some women have a higher risk of developing breast cancer based on their geographical location and ancestry. With ProFound AI Risk, patient care has never been more personalized. Specifically designed to factor in racial and ethnic backgrounds, ProFound AI Risk offers an equitable and inclusive approach to precision screening.3 The algorithm also factors in clinically relevant global screening guidelines and more than 15 country incidence and mortality reference tables, for alignment with that country’s general population. ProFound AI Risk also includes multiple risk factors found in a screening mammogram: Breast Density Subtle Mammographic Features

 Open the catalog to page 1
ProFound AI® Risk-2

Proven Solution Uniquely Positioned for Individualized Screening The field of mammography is moving from age-based screening to more individualized risk-based screening. ProFound AI Risk offers proven results that rapidly provide physicians and patients with an accurate, short-term absolute breast cancer risk score and risk category (low, general, moderate, and high).1,2 This leading-edge solution enables clinicians to easily adapt to evolving screening practices and personalized patient care. Unrivaled Accuracy and Clinical Performance ProFound AI Risk offers the highest Area Under the Curve...

 Open the catalog to page 2

All ICAD catalogs and technical brochures

  1. PowerLook®

    2  Pages

  2. SecondLook®

    1  Page

  3. VeraLook®

    2  Pages

*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.